Home
Adjuvant Global Health Technology Fund DE, 10% Owner: AN2 Therapeutics ANTX Sell · Filed 24/01/18
Trade details
- Type
- Insider sale
- Amount
- $1,652,427.45
- Shares · price
- 84,093 sh · $19.65 a share
- Held after
- 1,995,958 sh
- Trade date
- 24/01/16
- Filed
- 24/01/18
- Days to filing
- 2 days
Sold 4.0% of holdings
- Share of holding sold
- 4.0%
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 23/12/17~24/02/15Adjuvant Global Health Technology Fund DE's recent trades
- Adjuvant Global Health Technology Fund DE
SellAN2 Therapeutics
SellAN2 Therapeutics
ANTX
$312.6K
15,907 sh
$312.6K
Filed 24/01/18
Traded 24/01/16
- Adjuvant Global Health Technology Fund DE
Sell10b5-1 planAN2 Therapeutics
Sell10b5-1 planAN2 Therapeutics
ANTX
$24.6K
1,522 sh
$24.6K
Filed 23/11/16
Traded 23/11/14
- Adjuvant Global Health Technology Fund DE
Sell10b5-1 planAN2 Therapeutics
Sell10b5-1 planAN2 Therapeutics
ANTX
$4,651
288 sh
$4,651
Filed 23/11/16
Traded 23/11/14
- Adjuvant Global Health Technology Fund DE
SellAN2 Therapeutics
SellAN2 Therapeutics
ANTX
$1.4M
83,337 sh
$1.4M
Filed 23/10/03
Traded 23/09/29
- Adjuvant Global Health Technology Fund DE
SellAN2 Therapeutics
SellAN2 Therapeutics
ANTX
$256.6K
15,764 sh
$256.6K
Filed 23/10/03
Traded 23/09/29